Yaakov Zinberg
- Indexed articles, last 90 days
- 1
- Latest publication
- Aug 28, 2026
- Outlet visibility, for Chemical & Engineering News
- Top 500K sites
- Earliest in this view
- Aug 28, 2026
Latest articles
As clinical trials surge into Australia, HHS targets US bottlenecks (opens the original)
Read excerpt
As clinical trials surge into Australia, HHS targets US bottlenecks US policymakers have proposed reforms in an attempt to replicate Australia’s success in facilitating speedy Phase 1 clinical trials Recurring stories and special news packages from C&EN. CREATE Medicines, a biotech company based in Cambridge, Massachusetts, is developing three cancer medicines that have progressed to Phase 1 clinical trials, typically the first time people receive an experimental drug. Despite the robust biotech
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For Chemical & Engineering News, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.